87
Participants
Start Date
August 31, 2005
Primary Completion Date
April 30, 2009
Study Completion Date
November 30, 2009
Anti-CD20 (rituximab)
Placebo Comparator
Placebo intravenous infusion
Columbia University, New York
University of Pittsburgh, Pittsburgh
University of Miami, Miami
Indiana University-Riley Hospital for Children, Indianapolis
University of Minnesota, Minneapolis
Barbara Davis Center for Childhood Diabetes, Aurora
Childrens Hospital of Los Angeles, Los Angeles
University of California-San Francisco, San Francisco
Stanford University, Stanford
Benaroya Research Institute, Seattle
University of Florida, Gainesville
Joslin, Boston
University of Texas, Dallas
Walter and Eliza Hall Institute of Medical Research, Victoria
San Raffaele Hospital, Milan
The Hospital for Sick Children, Toronto
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
American Diabetes Association
OTHER
Juvenile Diabetes Research Foundation
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH